Back
Repeated administration of the combined dexamethasone-human corticotropin releasing hormone stimulation test during treatment of depression.
Journal article

Repeated administration of the combined dexamethasone-human corticotropin releasing hormone stimulation test during treatment of depression.

  • 1991-08-01
Published in:
  • Psychiatry research. - 1991
Adrenocorticotropic Hormone
Adult
Aged
Corticotropin-Releasing Hormone
Depressive Disorder
Dexamethasone
Female
Humans
Hydrocortisone
Male
Middle Aged
Trimipramine
English Human corticotropin releasing hormone (h-CRH) was administered to 14 patients with major depression, after premedication with an overnight dose of 1.5 mg dexamethasone. Cortisol response, expressed as area under the time course curve (AUC), was significantly higher in the 14 patients than in a group of 13 age-matched control subjects (9.4 +/- 7.6 ng x min x 1,000/ml vs. 3.1 +/- 3.6 ng x min x 1,000/ml). Corresponding AUC values for plasma adrenocorticotropic hormone (ACTH) were also significantly higher in patients than in control subjects (4.9 +/- 1.4 pg x min x 1,000/ml vs. 2.6 +/- 0.9 pg x min x 1,000/ml). After patients were treated with trimipramine (200 mg/day) for 6 weeks, the combined dexamethasone/h-CRH test was repeated. At that time, depression scores were significantly improved and the patients' cortisol response pattern became indistinguishable from that of controls. While plasma cortisol output normalized during treatment with trimipramine, ACTH release remained exaggerated. The combined dexamethasone/h-CRH challenge test may be of particular value in the detection of state-dependent changes of pituitary-adrenocortical neuroregulation.
Language
  • English
Open access status
closed
Identifiers
Persistent URL
https://sonar.ch/global/documents/243176
Statistics
Document views: 27 File downloads: